692 related articles for article (PubMed ID: 19073159)
1. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
[TBL] [Abstract][Full Text] [Related]
2. Association of IL10 promoter polymorphism in Italian Alzheimer's disease.
Bagnoli S; Cellini E; Tedde A; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
Neurosci Lett; 2007 May; 418(3):262-5. PubMed ID: 17420099
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease.
Capurso C; Solfrizzi V; Colacicco AM; D'Introno A; Frisardi V; Imbimbo BP; Lorusso M; Vendemiale G; Denitto M; Santamato A; Seripa D; Pilotto A; Fiore P; Capurso A; Panza F
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):177-82. PubMed ID: 19897004
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Capurso A; Panza F
Exp Gerontol; 2004 Oct; 39(10):1567-73. PubMed ID: 15501028
[TBL] [Abstract][Full Text] [Related]
5. Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
Zhang Q; Yu JT; Zhu QX; Zhang W; Wu ZC; Miao D; Tan L
Brain Res; 2010 Aug; 1348():216-21. PubMed ID: 20558149
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
Yu JT; Tan L; Ou JR; Zhu JX; Liu K; Song JH; Sun YP
Brain Res; 2008 May; 1210():216-22. PubMed ID: 18423577
[TBL] [Abstract][Full Text] [Related]
7. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
Xue S; Jia L; Jia J
Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
[TBL] [Abstract][Full Text] [Related]
8. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
9. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.
Vural P; Değirmencioğlu S; Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M
Acta Neurol Scand; 2009 Dec; 120(6):396-401. PubMed ID: 19744138
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.
Lio D; Licastro F; Scola L; Chiappelli M; Grimaldi LM; Crivello A; Colonna-Romano G; Candore G; Franceschi C; Caruso C
Genes Immun; 2003 Apr; 4(3):234-8. PubMed ID: 12700599
[TBL] [Abstract][Full Text] [Related]
11. The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population.
Sun Y; Shi J; Zhang S; Tang M; Han H; Guo Y; Ma C; Liu X; Li T
Neurosci Lett; 2005 Jun; 380(3):219-22. PubMed ID: 15862889
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
[TBL] [Abstract][Full Text] [Related]
13. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease.
Ma SL; Tang NL; Lam LC; Chiu HF
Neurobiol Aging; 2005 Jul; 26(7):1005-10. PubMed ID: 15748779
[TBL] [Abstract][Full Text] [Related]
14. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
[TBL] [Abstract][Full Text] [Related]
15. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial transcription factor A (TFAM) polymorphisms and risk of late-onset Alzheimer's disease in Han Chinese.
Zhang Q; Yu JT; Wang P; Chen W; Wu ZC; Jiang H; Tan L
Brain Res; 2011 Jan; 1368():355-60. PubMed ID: 20977898
[TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
[TBL] [Abstract][Full Text] [Related]
18. D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.
Zubenko GS; Hughes HB; Stiffler JS
Mol Psychiatry; 2001 Jul; 6(4):413-9. PubMed ID: 11443525
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.
Klimkowicz-Mrowiec A; Marona M; Wołkow P; Maruszak A; Styczynska M; Barcikowska M; Zekanowski C; Szczudlik A; Slowik A
Dement Geriatr Cogn Disord; 2009; 28(5):461-4. PubMed ID: 19940477
[TBL] [Abstract][Full Text] [Related]
20. CD14 receptor polymorphism and Alzheimer's disease risk.
Combarros O; Infante J; Rodríguez E; Llorca J; Peña N; Fernández-Viadero C; Berciano J
Neurosci Lett; 2005 May 20-27; 380(1-2):193-6. PubMed ID: 15854776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]